Pictet Asset Management Holding SA »

Celldex Therapeutics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-03-31 $63M 1.5M 41.97

More positions owned by Pictet Asset Management Holding SA

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
Apple (AAPL)
Amazon (AMZN)
Republic Services (RSG)
Alphabet Cap Stk Cl C (GOOG)
Nxp Semiconductors N V (NXPI)
Meta Platforms Cl A (META)
Waste Connections (WCN)
Synopsys (SNPS)
Applied Materials (AMAT)
Waste Management (WM)
Alphabet Cap Stk Cl A (GOOGL)
Xylem (XYL)

View all positions for Pictet Asset Management Holding SA

Top funds holding Celldex Therapeutics

FMR
Wellington Management Company
BlackRock
Vanguard Group
Eventide Asset Management
T. Rowe Price Associates
Kynam Capital Management
Bellevue Group
Pictet Asset Management Holding SA
Geode Capital Management
Rock Springs Capital Management
Point72 Asset Management
Marshall Wace
Redmile Group
Commodore Capital

View all funds holding Celldex Therapeutics